Ticker
AVTXCompany Name
AVALO THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Revenues | Stock Based Compensation | Stock Based Compensation Margin |
---|---|---|---|
6/30/2025 | $ 441K | $ 10.71M | 2428.8% |
3/31/2025 | $ 441K | $ 8.46M | 1919.27% |
12/31/2024 | $ 441K | $ 5.85M | 1326.98% |
9/30/2024 | $ 820K | $ 3.72M | 454.15% |
6/30/2024 | $ 807K | $ 2.83M | 350.56% |
3/31/2024 | $ 1.45M | $ 3.25M | 224.21% |
12/31/2023 | $ 1.92M | $ 3.48M | 180.72% |
9/30/2023 | $ 2.25M | $ 3.54M | 157.51% |
6/30/2023 | $ 16.96M | $ 3.32M | 19.58% |
3/31/2023 | $ 17.35M | $ 3.1M | 17.85% |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
SB Comp. / Revenues
(=) SB Comp %
SB Comp % for AVALO THERAPEUTICS INC is calculated as follows: SB Comp. [ $ 5.94M ] / Revenues [ $ -3.52M ]
(=) SB Comp % [ 0% ]
Minimum
Mar 31, 2023
Maximum
Jun 30, 2025
Average
Median
filtered constituents | 2.98K |
---|---|
min | -3.97% |
max | 8.43% |
average | 1.72% |
median | 1.04% |
std | 1.9% |